Chin Kathleen, Zhao Di, Tibuakuu Martin, Martin Seth S, Ndumele Chiadi E, Florido Roberta, Windham B Gwen, Guallar Eliseo, Lutsey Pamela L, Michos Erin D
Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Johns Hopkins University School of Medicine, and.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21287.
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1227-1236. doi: 10.1210/jc.2016-3743.
Physical activity (PA) is associated with 25-hydroxyvitamin D [25(OH)D] levels. Both are associated with atherosclerotic cardiovascular disease (ASCVD), but their joint association with ASCVD risk is unknown.
To examine the relationship between PA and 25(OH)D, and assess effect modification of 25(OH)D and PA with ASCVD.
Cross-sectional and prospective study.
Community-dwelling cohort.
A total of 10,342 participants free of ASCVD, with moderate- to vigorous-intensity PA assessed (1987 to 1989) and categorized per American Heart Association (AHA) guidelines (recommended, intermediate, or poor).
Serum 25(OH)D levels (1990 to 1992) and ASCVD events (i.e., incident myocardial infarction, fatal coronary disease, or stroke) through 2013.
Participants had mean age of 54 years, and were 57% women, 21% black, 30% 25(OH)D deficient [<20 ng/mL (<50 nmol/L)], and <40% meeting AHA-recommended PA. PA was linearly associated with 25(OH)D levels in whites. Whites meeting recommended PA were 37% less likely to have 25(OH)D deficiency [relative risk, 0.63 (95% confidence interval [CI], 0.56, 0.71)]; there was no significant association in blacks. Over 19.3 years of follow-up, 1800 incident ASCVD events occurred. Recommended PA was associated with reduced ASCVD risk [hazard ratio [HR], 0.78 (95% CI, 0.65, 0.93) and 0.76 (95% CI, 0.62, 0.93)] among participants with intermediate [20 to <30 ng/mL (50 to <75 nmol/L)] and optimal [≥30 ng/mL (≥75 nmol/L)] 25(OH)D, respectively, but not among those with deficient 25(OH)D (P for interaction = 0.04).
PA is linearly associated with higher 25(OH)D levels in whites. PA and 25(OH)D may have synergistic beneficial effects on ASCVD risk.
体力活动(PA)与25-羟基维生素D[25(OH)D]水平相关。两者均与动脉粥样硬化性心血管疾病(ASCVD)有关,但其与ASCVD风险的联合关联尚不清楚。
研究PA与25(OH)D之间的关系,并评估25(OH)D和PA对ASCVD的效应修正作用。
横断面和前瞻性研究。
社区居住队列。
共有10342名无ASCVD的参与者,评估了其中等至剧烈强度的PA(1987年至1989年),并根据美国心脏协会(AHA)指南进行分类(推荐、中等或较差)。
血清25(OH)D水平(1990年至1992年)和截至2013年的ASCVD事件(即新发心肌梗死、致命性冠心病或中风)。
参与者的平均年龄为54岁,女性占57%,黑人占21%,25(OH)D缺乏[<20 ng/mL(<50 nmol/L)]者占30%,达到AHA推荐PA者<40%。在白人中,PA与25(OH)D水平呈线性相关。达到推荐PA的白人发生25(OH)D缺乏的可能性降低37%[相对风险,0.63(95%置信区间[CI],0.56,0.71)];在黑人中无显著关联。在19.3年的随访中,发生了1800例新发ASCVD事件。在25(OH)D水平中等[20至<30 ng/mL(50至<75 nmol/L)]和最佳[≥30 ng/mL(≥75 nmol/L)]的参与者中,推荐的PA分别与降低ASCVD风险相关[风险比[HR],0.78(95%CI,0.65,0.93)和0.76(95%CI,0.62,0.93)],但在25(OH)D缺乏的参与者中则不然(交互作用P=0.04)。
在白人中,PA与较高的25(OH)D水平呈线性相关。PA和25(OH)D可能对ASCVD风险具有协同有益作用。